New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North AmericaBy
- Franco Muggia, MD
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.
Hardbound, 1440 Pages
Published: May 2012